Table 1.
Clinical characteristics | Cases | miR-409 expression |
P values | |
---|---|---|---|---|
n = 143 | Low (n = 72) | High (n = 71) | ||
Age | 0.677 | |||
≤ 55 | 70 | 34 | 36 | |
> 55 | 73 | 38 | 35 | |
Gender | 0.454 | |||
Male | 79 | 42 | 37 | |
Female | 64 | 30 | 34 | |
Location | 0.450 | |||
Head of pancreas | 89 | 47 | 42 | |
Others | 54 | 25 | 29 | |
CEA (μg/ml) | 0.681 | |||
< 4.3 | 81 | 42 | 39 | |
≥ 4.3 | 62 | 30 | 32 | |
CA199 (U/mL) | 0.649 | |||
< 37 | 90 | 44 | 46 | |
≥ 37 | 53 | 28 | 25 | |
Tumor size (cm) | 0.357 | |||
< 2 | 70 | 38 | 32 | |
≥ 2 | 73 | 34 | 39 | |
Differentiation | 0.678 | |||
Well-moderate | 68 | 33 | 35 | |
Poor | 75 | 39 | 36 | |
Lymph node metastasis | 0.001 | |||
Negative | 96 | 39 | 57 | |
Positive | 47 | 33 | 14 | |
TNM stage | 0.004 | |||
I-II | 108 | 47 | 61 | |
III | 35 | 25 | 10 |